Business Wire
BusinessJPMorgan’s Q2 trading revenues jump 35% as markets activity picks up, raising questions about how long it lastsThe Apex TimesBusinessYahoo Finance frames Seagate’s storage roadmap as an AI-infrastructure advantage versus AMDThe Apex TimesBusinessTesla faces its biggest-ever China recall as regulators target software-related safety concernsThe Apex TimesBusinessBank of America shares face “sell announcement” worries, but fund managers keep piling into stocks, Yahoo Finance reportsThe Apex TimesBusinessWalmart’s Earnings Beat and Guidance Raise Still Triggered a Selloff, a CFO Comment Appears to Have Done the DamageThe Apex TimesBusinessDeere Posts Solid Fiscal Q3, Lifts Full-Year Net Income View as Analysts Flag Limits on an Agriculture TurnaroundThe Apex TimesBusinessUBS questions the momentum behind Walmart’s core U.S. growth after a mixed quarter, a Yahoo Finance report saysThe Apex TimesBusinessApple disclosed that Ireland received about $17.1 billion of its tax payments, about 40% of its global totalThe Apex TimesBusinessNvidia’s next quarter looms large as investors look for a fresh catalystThe Apex TimesBusinessNvidia in talks over possible tie-up with AI chip maker Rebellions, report saysThe Apex TimesBusinessKaos Capital presses for Capricor governance change as Eli Lilly doubles down on vaccinesThe Apex TimesBusinessFriday Checkout: Walmart and Target underscore grocery as retailers’ differentiatorThe Apex TimesBusinessJPMorgan’s Q2 trading revenues jump 35% as markets activity picks up, raising questions about how long it lastsThe Apex TimesBusinessYahoo Finance frames Seagate’s storage roadmap as an AI-infrastructure advantage versus AMDThe Apex TimesBusinessTesla faces its biggest-ever China recall as regulators target software-related safety concernsThe Apex TimesBusinessBank of America shares face “sell announcement” worries, but fund managers keep piling into stocks, Yahoo Finance reportsThe Apex TimesBusinessWalmart’s Earnings Beat and Guidance Raise Still Triggered a Selloff, a CFO Comment Appears to Have Done the DamageThe Apex TimesBusinessDeere Posts Solid Fiscal Q3, Lifts Full-Year Net Income View as Analysts Flag Limits on an Agriculture TurnaroundThe Apex TimesBusinessUBS questions the momentum behind Walmart’s core U.S. growth after a mixed quarter, a Yahoo Finance report saysThe Apex TimesBusinessApple disclosed that Ireland received about $17.1 billion of its tax payments, about 40% of its global totalThe Apex TimesBusinessNvidia’s next quarter looms large as investors look for a fresh catalystThe Apex TimesBusinessNvidia in talks over possible tie-up with AI chip maker Rebellions, report saysThe Apex TimesBusinessKaos Capital presses for Capricor governance change as Eli Lilly doubles down on vaccinesThe Apex TimesBusinessFriday Checkout: Walmart and Target underscore grocery as retailers’ differentiatorThe Apex TimesBusinessJPMorgan’s Q2 trading revenues jump 35% as markets activity picks up, raising questions about how long it lastsThe Apex TimesBusinessYahoo Finance frames Seagate’s storage roadmap as an AI-infrastructure advantage versus AMDThe Apex TimesBusinessTesla faces its biggest-ever China recall as regulators target software-related safety concernsThe Apex TimesBusinessBank of America shares face “sell announcement” worries, but fund managers keep piling into stocks, Yahoo Finance reportsThe Apex TimesBusinessWalmart’s Earnings Beat and Guidance Raise Still Triggered a Selloff, a CFO Comment Appears to Have Done the DamageThe Apex TimesBusinessDeere Posts Solid Fiscal Q3, Lifts Full-Year Net Income View as Analysts Flag Limits on an Agriculture TurnaroundThe Apex TimesBusinessUBS questions the momentum behind Walmart’s core U.S. growth after a mixed quarter, a Yahoo Finance report saysThe Apex TimesBusinessApple disclosed that Ireland received about $17.1 billion of its tax payments, about 40% of its global totalThe Apex TimesBusinessNvidia’s next quarter looms large as investors look for a fresh catalystThe Apex TimesBusinessNvidia in talks over possible tie-up with AI chip maker Rebellions, report saysThe Apex TimesBusinessKaos Capital presses for Capricor governance change as Eli Lilly doubles down on vaccinesThe Apex TimesBusinessFriday Checkout: Walmart and Target underscore grocery as retailers’ differentiatorThe Apex TimesBusinessJPMorgan’s Q2 trading revenues jump 35% as markets activity picks up, raising questions about how long it lastsThe Apex TimesBusinessYahoo Finance frames Seagate’s storage roadmap as an AI-infrastructure advantage versus AMDThe Apex TimesBusinessTesla faces its biggest-ever China recall as regulators target software-related safety concernsThe Apex TimesBusinessBank of America shares face “sell announcement” worries, but fund managers keep piling into stocks, Yahoo Finance reportsThe Apex TimesBusinessWalmart’s Earnings Beat and Guidance Raise Still Triggered a Selloff, a CFO Comment Appears to Have Done the DamageThe Apex TimesBusinessDeere Posts Solid Fiscal Q3, Lifts Full-Year Net Income View as Analysts Flag Limits on an Agriculture TurnaroundThe Apex TimesBusinessUBS questions the momentum behind Walmart’s core U.S. growth after a mixed quarter, a Yahoo Finance report saysThe Apex TimesBusinessApple disclosed that Ireland received about $17.1 billion of its tax payments, about 40% of its global totalThe Apex TimesBusinessNvidia’s next quarter looms large as investors look for a fresh catalystThe Apex TimesBusinessNvidia in talks over possible tie-up with AI chip maker Rebellions, report saysThe Apex TimesBusinessKaos Capital presses for Capricor governance change as Eli Lilly doubles down on vaccinesThe Apex TimesBusinessFriday Checkout: Walmart and Target underscore grocery as retailers’ differentiatorThe Apex Times
Back to front
CVS Health spotlights heart disease disparities in communities as it urges better access to care
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 21, 9:56 AM EDT

CVS Health spotlights heart disease disparities in communities as it urges better access to care

In a new Access Newswire feature carried by Yahoo Finance, CVS Health highlights how heart disease outcomes can vary widely across communities and frames access to prevention and treatment as a key lever to narrow gaps.

2 min readEditor-approved Apex article

CVS Health used a new August 21, 2026 feature, distributed through Access Newswire and republished by Yahoo Finance, to put a spotlight on heart health disparities and what it calls the need for better access to care. The piece, titled “Every Community Deserves a Healthier Heart,” argues that heart disease affects different communities differently due to a mix of factors, including barriers that influence who can get timely prevention, diagnosis, and treatment.

The article’s central message is that improving cardiovascular outcomes is not only a matter of medical advances but also of access. CVS Health said that “access to care must be” addressed, positioning equitable access to services as an essential part of any strategy to reduce the burden of heart disease across the country.

While the feature describes the equity problem broadly, it does not, in the information available for this write-up, provide detailed program specifics such as which exact markets or patient populations are targeted, what measurable targets are being used, or what timelines govern any initiatives. The piece also does not lay out specific funding amounts or named partners in the text available here.

Because the item is presented as a promotional-style corporate feature rather than a regulatory filing or an earnings document, it also does not disclose operational metrics tied to the company’s financial results. There were no reported quarter-over-quarter figures, cost estimates, or guidance in the material referenced for this story.

For CVS Health, the framing aligns with the company’s long-running role as a major provider and manager of healthcare access, including retail pharmacy, pharmacy services, and healthcare delivery through its broader ecosystem. In this context, equity-focused messaging often intersects with where consumers seek care, how quickly they can access prescriptions and clinical services, and how health systems coordinate prevention activities.

In terms of what is still unclear, the feature, as reflected in the text available for this story, does not spell out the precise mechanisms CVS Health plans to use to close gaps in heart outcomes. It also does not offer granular details on interventions such as screening programs, disease management pathways, or community partnerships, nor does it provide supporting statistics within the accessible excerpt.

Looking ahead, readers may want to watch for follow-on disclosures that typically accompany equity or prevention campaigns. Those could include partner announcements, program rollouts with specific geographies or service lines, and any performance reporting that connects access initiatives to measurable outcomes over time.

Why It Matters

  • Heart disease disparities remain a persistent public health challenge, and large healthcare access platforms increasingly face scrutiny about who benefits from care.
  • Equity-oriented initiatives can affect how consumers engage with prevention services, including screenings and ongoing chronic care management.
  • For companies like CVS Health, where distribution and clinical access are core capabilities, messaging can indicate strategic priorities, even when detailed execution is not disclosed.
  • Absent concrete metrics in the feature, the practical impact will depend on what CVS ultimately launches and whether it reports measurable results.

Sources

Key Facts

  • CVS Health published an Access Newswire feature on August 21, 2026 titled “Every Community Deserves a Healthier Heart.”
  • The feature argues heart disease disproportionately affects different communities for a variety of reasons.
  • CVS Health emphasizes improving access to care as a requirement to address those disparities.
  • The material available here does not provide specific program details, funding amounts, partner names, or measurable targets.
  • The feature is framed as corporate messaging rather than as a financial or regulatory disclosure.

Healthcare Related

Aug 21, 5:56 AM EDT
The Apex Times

European Commission approves Johnson & Johnson’s TECVAYLI plus daratumumab for relapsed/refractory multiple myeloma

The European regulator has authorized a Tecvayli (teclistamab) and daratumumab combination for patients with relapsed or refractory multiple myeloma, positioning the doublet as a potential new standard of care on the back of Phase 3 results showing statistically significant gains in progression-free survival and overall survival versus standard regimens.

European Commission approves Johnson & Johnson’s TECVAYLI plus daratumumab for relapsed/refractory multiple myeloma
The Apex Times